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Ayurveda, a branch of AYUSH system of health care in India is considered as alternative/complementary of medicine 
(CAM) in WHO. Here, its products are covered under ―drug and cosmetics‖ act but in abroad they are supplements or 
functional foods. The aim of Ayurveda is to maintain the wellness of a healthy person and to treat a patient. For treatment, 
Ayurveda adopts 3 approaches i.e., (1) Daivavyapasharya (दवैव्यपाश्रय) chikitsa ) (ypareht enivid2(  Yuktivyapashraya (युक्तिव्यपाश्रय) 
chikitsa (Rational therapy) 3 Satvavajaya (सत्वावजय) chikitsa (Psychotherapy) and focuses to enhance the Vyadhikshmatwa 
(capacity to fight against spread of pathogenesis by strengthening all 7 dhatus (rasa, rakta, meda, mansa, asthi, majja and 
shukra). The disease COVID-19 falls under ―Bhootvidya (GrahaVidya)‖, which is one of the 8 branches of ―Astanga 
Ayurveda‖. It is an ―Agantuja‖ disease, where the disease symptoms appear in 1st stage followed by its spread in the body. Thus, 
progress of disease (Samprapti) has been considered under concept of shatkriyakala (6 stages of disease development), which 
has been given high importance for deciding the stage of disease progress and its treatment protocol. Here, we have described 
the introduction to Astang Ayurveda, concept of disease pathogenesis and holistic approach of treatment in respect to 
management of COVID-19. It specifically covers symptom based stage of disease progress and its targeted treatment guideline 
by including all 3 approaches of treatment, described above. Here, the current line of diagnosis, treatment and research related 
to COVID-19 management has been included, which are reported by basic scientists and physicians of allopathic system. These 
are indexed in Pubmed and web of science and also described in classical text books of Ayurveda. The same has been reviewed 
and summarized here, with an objective of possible correlation between the 2 languages of science of health care.  
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The management of COVID-19 patient’s-guideline, 
developed and released by WHO, is being followed 
all over the World by doctors of conventional system 
of medicine. However, Ayurveda, one of the AYUSH 
systems, in India, needs a definite guideline and 
protocol for management of these patients. Ayurveda, 
an ancient science of life, has its own drug-formulary, 
line of diagnosis and treatment, based on principles of 
Astang Ayurveda. It is in practice, since centuries, 
across the country, with a huge network of its 
physicians and surgeons. The COVID -19 is a 
pandemic condition caused due to novel coronavirus 
(2019-nCoV), now called as Severe Acute Respiratory 
Syndrome Corona Virus -2 (SARS CoV 2). Since the 
report of the first case of the COVID-19 pandemic in 
India on 30
th
 January 2020, the Ministry of Health and 
Family Welfare have confirmed a total of 134,823 
cases, 57720 recoveries and 4021 deaths in the 
country as on dated 25.05.2020
(ref. 1)
. 
Pathogenesis of COVID-19 
SARS-CoV -19 comes under Human coronaviruses 
(HCoVs). Its spike’s protein consists of S protein, 
having domains: S1 and S2, which binds to receptors 
on the host cells. The CoVs are RNA viruses belonging 
to the family of Coronaviridae
2
. Up to now, 6 strains of 
viruses have been identified. These are HCoV-229E, 
HCoV-NL63, HCoV-OC43, HCoV-HKU1, severe 
acute respiratory syndrome coronavirus (SARS-CoV) 
and Middle East respiratory syndrome coronavirus 
(MERS-CoV)
3
. As per existing literature, the CoV 
attaches itself to host cell through its spike having S1 
protein and triggers host’s cell-membrane hydrolysis, 
resulting fusion of virus with the host cell, through the 
S2 domain. The host cell receptors include (1) 
aminopeptidase N (2) Angiotensin converting enzyme-
2 (ACE-2), dipeptidylpeptidase-4 (DPP-4) & 9-O 
acetylated sialic acid. 
Primarily, it attacks the respiratory system, but it 
has potential to affect other organs also, because of 
—————— 
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versatile availability of these host receptors. In span 
of 21 days, its early-stage is asymptomatic, but at later 
stage, slowly symptoms of fever, cough, fatigue, 
dyspnea, shortness of breath appears. At later stage, 
up 7-14 days, symptoms of pneumonia and bronchitis 
may appear in a few cases, but in most cases the 
symptoms and viral load disappear within 14 to  
21 days
4
. Some patients undergo uncontrolled  
host-immune response, leading to a life-threatening 
condition of cytokine release syndrome (CRS).  
It is more severe in those people who have 
cardiometabolic, diabetes mellitus, obesity, arterial 
hypertension. The lymphopenia and high 
procalcitonin are reported in children. After attack, it 
induces various biochemical activities in the host cell 
by involving several signaling pathways e.g. MAP 
kinases, NFkB etc, which result in apoptosis of the 
host cell
5
. By using transcription profile and 
bioinformatics tools, drug docking of anti-signature 
perturbation analysis the role of inhibitors of MAP 
kinases, serine-threonine kinase, mammalian target of 
rapamycin (mTOR) and I kappa B Kinase (IKK) can 
be used to develop new drugs. Thus, these molecules 
may be used as target for developing new drugs in 
addition to the development of vaccines. Researchers 
are moving towards repurposing of existing drugs for 
flu influenza, BCG vaccine, drugs for other metabolic 
disorders, but in this direction phytochemicals from 
various medicinal plants are also being explored 
through bioinformatics, drug docking and simulation 
tools. The potent inhibitors of the host enzyme 
TMPRSS2 is also in progress
6
. The lead is being 
taken from the list of drugs, which are already in use 
for treatment of symptoms, appearing in patients of 
COVID-19. No proven and effective therapy for 
SARS-CoV-2 has been reported till date. The 
currently antiviral drugs, biological response 
modifiers and inhibitors of RAAS are being explored. 
The drugs, diet modification or physiological 
changes, which may influence the expression or 
activity of ACE-2 proteins is mainly being explored 
as a new drug. In this series, several synthetic 
molecules and also phytochemicals of different plants 
are being tested by bioinformatics tools. The 
hydroxychloroquine (HCQ) has speeded up COVID-
19 virus clearance as measured by Real time 
Polymerase chain reaction (RT-PCR) data in 
experiments, but meta-analysis of several trials 
showed negative results in several clinical trials. Even 
the total death was also more. Chloroquine 
compounds get accumulated in the endolysosomal 
system and raise the pH, which we hypothesize would 
counteract HMGB1 from operating as a detergent and 
thus preclude leakage of DAMP/PAMP molecules to 
the cytosol
7
. Plasma therapy is another option for 
treatment. Here antibodies in plasma from recovered 
patients are saved by plasmapheresis or affinity 
column- chromatography and properly sterilized and 
pathogen inactivated for use as substitution therapy in 
critically ill COVID 19 patients. The phytochemicals 
which induce immune system are good at its control 
especially as prophylactic measure, which can be 
objectively measured by assessment of natural 
antibodies, non-specific antimicrobial proteins, 
interferons, cytokines and cellular elements (i.e. 
natural killer cells), which are the most common tools 
to assess the immune modulation
8
. The effect of all 
the 3 approaches of treatment (not only medicine), 
described in Ayurveda, can be studied as intervention. 
This guideline has covered those symptoms and a list 
of medicines, which are recommended in Ayurvedic 
texts. So, at one hand this document would help our 
Ayurvedic physicians for recommending ayurvedic 
drugs for specific step of disease progress (Samprapti) 
and on the other hand, it will also help the basic 
scientists to explore the phytochemicals, present in 
these plants. This exploratory research would become 
stronger, once we collect the clinical data based on 
treatment with this protocol, which is one of the 
objectives of this document. 
 
Symptomatology of COVID 19 infection as per 
WHO 
COVID-19 affects different people in different 
ways. Most infected people will develop mild to 
moderate illness and recover without hospitalization
9
.  
Early symptoms include fever, dry cough, and 
tiredness. The late symptoms include aches and pains, 
sore throat, diarrhea, conjunctivitis, headache, and 
loss of taste or smell. Skin rash or discoloration of 
fingers or toes is other symptoms of the disease. 
Serious symptoms includes, difficulty breathing or 
shortness of breath, pain in chest, loss of speech or 
movement. The complications include severe 
pneumonia, septic shock, acute respiratory distress 





An Ayurvedic view on COVID-19 
Acharya Sushruta
11
 has narrated that diseases do 
not develop without the involvement of doshas (bio-




humours). Hence, an intelligent physician should treat 
the unmentioned diseases as per the symptoms 
produced by doshas. As per Charaka samhita
12,13
, 
there are several diseases which are not described in 
the texts with names and such diseases are to be 
treated after examining the doshas and other factors 
involved in their manifestation. As per Ayurvedic 
classics, the present Acute Respiratory Syndrome 
Coronavirus 2 (SARS-CoV-2) may be considered as 
an Aupasargika Roga (communicable disease) which 
is pandemic in nature. The involvement of virus is the 
primary event in terms of Upasarga (infection) and 
this Aupsargika Sankramaka Roga (communicable 
infectious disease) which affects the susceptible host 
in whom Vyadhikshamatva (immune strength) is 





 has clearly 
stated the involvement of kapha in sankramaka roga 
that spreads especially through nasal cavity causing 
dry cough, nasal congestion, loss of smell, fever, 
tiredness etc. This may also resemble the 
Janapododwamsa janya vikara as described in texts 
of Ayurveda
16
. So, without making a debate on to the 
nomenclature of the disease, the management of 
Agantuja vikara (exogenous disorder) should be done 
on the lines of nijavikara (endogenous disorder)
 17
, 
with the assessment of the dosha (bio-humours), 
dushya (which gets vitiated), adhishthana (seat) and 
avastha (stage) involved, and accordingly the 
management of the COVID-19 may be done.  
The ―Ashtanga Ayurveda‖, describes its 8 branches 
to diagnose and treat the sufferings. These are the 
specialities, and being developed on clinical and 
experimental scientific tools. These includes 
Kayachikitsa, Balachikitsa (Kaumarbhritya), 
Grahachikitsa (Bhootavidya), Shalakya Tantra, 
Shalya Tantra, Vishachikitsa (Agadatantra), 
Rasayana and Vajikarana
18
. Regarding the types of 
diseases, it is broadly divided into: (1) Nija 
(endogenous) or (2) Agantuja (exogenous)
19
. In the 1
st
 
case, pathogenesis starts within the body and then 
manifests as a disease and in the 2
nd
 case, the 
manifestation of the disease is at 1
st
 stage and then 
followed by disturbances in all the seven dhatus, 
leading to various complications. This whole process 
of pathogenesis is defined as samprapti 
(etiopathogenesis), which is divided in to 6 stages 
called shatkriyakala
20
. Thus, for deciding the 
treatment, it is important to know the stage of disease. 
However, in Ayurveda, the treatment-prescription is 
personalized, because it varies from person to person, 
based on his genetic constitution (Prakriti), kala, bala 
and other environmental factors
21
. This is now being 
defined as personal/customized medicine, in 
conventional system of health care. Regarding the aim 
of Ayurveda, it is defined to maintain the wellness of 
a healthy person and to treat a patient, inflicted with a 
disease. ―स्वस्थस्यस्वास््यरक्षणंअतरुस्यक्तवकारप्रशमनंच‖ (चरकसंक्तिता, 
सूत्रस्थान 30/26). 
Further, regarding treatment, the holistic approach 
of Ayurveda has four components for patient care, 
which includes (1) Patient, (2) Attendant (Family 
members are paramedical staff), (3) Physician and the 
(4) Drug/Procedures
22
. When we talk of drug, then it 
includes (1) Animal products, (2) Herbal products and 
(3) Mineral products
23
 which may be of 5 types of 
primary Kalpana (pharmaceutics/ dosage forms)
24
 and 
their derived formulations. In Ayurveda, treatment 
through non-pharmacological approaches, have been 
given at most important, as it considers Ahar (diet), 
Nidra (sleep) and Brahmacharya (Code of conduct 
related to mental and physical activities) as the 3 
pillars for good health, which need to be followed in 
day to day life
25
. These factors are enough to maintain 
the Ayu, which consists of (1) Sharira, (2) Indriya, (3) 
Mana and (4) Atma
26
, which ultimately maintains the 
mental, physical and spiritual health. However, for 
eliminating the disease, the cause of disease and 
accumulated toxins in the body, must be removed at 
1
st
 stage and for that procedures related to body 
purification, covering langhan and panchakarma 
therapy have been described. However, when a person 
gets a disease, due to three broad causes i.e., (1) 
Asatmendriyartha samyoga-ऄसात््येक्तरियाथथसंयोग (improper 
use of sense-organs), (2) Pragyaparadha-प्रज्ञापराध 
(knowingly doing wrong deeds) and (3) Parinama-
पररणाम (time, place and season)
27
, then holistic line of 
treatment is recommended, which also consists of  
3 types. These are: (1) Daivavyapasharya (दैवव्यपाश्रय)२ 
(Yuktivyapashraya (युक्तिव्यपाश्रय),)३ (Satvavajaya 
(सत्वावजय)
28
. The दैवव्यपाश्रय has been defined as spiritual 
therapymeans ―treatment by using mantra, talisman, 
wearing of gems, auspicious offerings, gifts, 
oblations, atonement, fasting, going to pilgrimage 
etc.
29
. In traditional concept, the holistic approach to 
healing includes the body, mind and spirit, which 
involves both, community and environment, along 
with herbal remedies and ceremonies. Although 
Western cultures have accepted some traditional 
methods of relaxation and exercise, such as yoga and 
tai chi
30
, but many more interventions from Ayurveda 
can be included for scientific validation. Interestingly, 




in recent years enough data have been published 
related to mindfulness, meditation, and related 
constructs, altering expectations, remoralization and 
instilling hope. Other intervention tools may include 
inducing the states of cognitive and emotional 
flexibility through specific symbolic interventions we 
term "flexibility primers" that can include  
images, metaphors, music and other media
31
. Other 
intervention includes spirit-body healing, a 
hermeneutic phenomenological research study. The 
Max Van Manen's method of researching the lived 
experience includes (1) go into darkness, (2) go 
elsewhere, (3) art becomes the turning point, (4) slip 
through the veil, (5) know the truth and trust the 
process, (6) embody your spirit, (7) feel the healing 
energy of love and compassion, and (8) experience 
transcendence
32
. A study from Bangladesh has 
reported that traditional healers use both religious and 
non-religious healing practices. The key religious 
healing practices reportedly included Kalami, 
Bhandai, and Spiritual Healing, whereas the non-
religious healing practices included Sorcery, Kabiraji, 
and Home Medicine
33
. However, the interpretation 
and objective parameters to measure the degree of 
mindfulness, type of questions regarding what can 
and cannot be inferred from self-report measures and 
considerations regarding the structure of study design 
and data analyses are still to be answered. Many 
studies have used clinical hypnosis along with 
psychological and spiritual aspects to have better 
results, especially when, death is preceded by an 
incurable disease. It is important to note that 
devavyapasharya can also be considered under 
palliative care (the word came from a Latin word 
―pallium-mantle‖), which offers a mantle of 




Though the researches are going on
35
 a meta-
analysis using 12-step-oriented interventions has been 
compared with active and inactive controls for 
spiritual/religious (S/R) interventions, and have 
concluded some positive response but they were 
statistically insignificant. The authors suggested 
having studies on more than 12-step-oriented S/R 
interventions
36
. This training is being given more to 
the nursing staff than the doctors in modern medicine, 
but in Ayurveda, it is the part of training of a qualified 
Ayurvedic doctor. Now similar therapeutic approach 
is being applied to the patients in the name of 
―spiritual healing‖
37
, especially in cancer patients
38
. It 
has shown significant changes in blood hormones in a 
double blind clinical trial (Effects of Spiritist "passe" 
(Spiritual healing) on stress hormone, pain, 
physiological parameters and length of stay in preterm 




If all of them are applied simultaneously then there 
could be wonders in field of health care. This is the 
USP (Unique Selling Point) of Ayurveda and 
unfortunately, neither it is being taught nor being 
propagated in clinical practices. Most of the 
physicians depend on Yuktivyapashraya only, which 
is similar to allopathic system of medicine means only 
medicine.  
 
Nidana (Cause) of COVID 19 infection  
As of today, infection with the new coronavirus 
(severe acute respiratory syndrome coronavirus 2, or 
SARS-CoV-2) causes coronavirus disease 2019 
(COVID-19). The virus appears to spread easily from 
person to person among those in close contact (within 
about 6 feet, or 2 m), Bhoota (afflictions by invisible 
objects)
40
, Krimi (microorganisms), close contact with 
the infected persons, consumption of denatured 
plants, polluted air and infected animals, respiratory 
droplets released when the infected person coughs, 
sneezes or talks, touches a surface with the virus on it 
and then touches his or her mouth, nose or eyes
41
.  
As per Ayurveda, this type of infection occurs due to 
Pragyaparadha (intellectual blasphemy; knowingly 





 (uncleanliness). In fact, the 
Pragyaparadha is linked to fear, which directly 
affects the immune system, which is considered under 
psychoneuroimmunology
44
. The fear can be defined 
by many terms, but in NAMASTE portal of AYUSH 
some related terms have been given which can be 
covered in this heading and also in ―Bhoot Vidya:, 
defined above. These terms are देवबलप्रवतृ्त रोग: (diseases 
caused by supernatural agencies); क्तवद्युदशक्तनकृत-रोगः 
(diseases caused by lightning and thunder) and 
क्तपशाचाक्तदकृत-रोगः (diseases caused by evil spirits)
18
. The 
term Asuchi referes to hygiene, which is again related 
to immunity and also more chances of microbial 
infection, spread in community
45
. This can be now 
correlated with physical distancing and other 
recommendations of WHO regarding COVID-19. 
 
Ayurvedic view of Samprapti (Pathogenesis) of COVID 19 
infection 
As per Ayurveda the pathological probability of 
severe acute respiratory syndrome coronavirus  




2 infection may be due to accumulation and 
aggravation of Kapha Vata (some opine –Vata 
Kapha) followed by involvement of Pitta within the 
Pranavahasrotasa (channels carrying prana/ channels 
of respiration/respiratory system). Later on, other 
srotas viz. Rasavaha (channels carrying nutrient 
fluids), Raktavaha (channels carrying blood tissue), 
Annavahasrotas (digestive tract), Purishavahasrotas 
(channels in which faeces is formed and excreted) etc. 
also get affected. In this infection, dushya are initially 
rasa and rakta (components of blood) followed by the 
involvement of all other dhatus in the advanced 
condition. Due to mandaagni (hypo functioning of 
bio-fire), there is a derangement in digestion and 
metabolic activities. In Ayurveda, this term is widely 
used in pathogenesis of all diseases. There are 13 
types of Agnies. The master agni is ―Jathraagani‖, 
which is related to GIT tract function, means 
digestion and absorption. The remaining 12 agnies are 
five-bhutaagnies and 7 dhatwaagnies, working at 
tissue and cellular level. In modern science, these 
terms can be correlated with metabolic enzymes in 
cells and its abnormal activity results to accumulation 
of modified proteins, which needs to be removed by 
lysozomal proteases. This leads to development and 
accumulation of Ama. The term ―Ama‖ has been 
defined in Ayurveda as ―undigested and improperly 
processed food and metabolites‖. This accumulation 
at cell and tissue levels further blocks the channels 
and receptors which have been defined in Ayurveda 
as ―Srotovarodha‖. In case of COVID-19, it is mainly 
the obstruction in the pranavahasrotas which is 
related to respiratory system. This obstruction induces 
abnormality in the Kapha-Vatadosha to a greater 
extent, which may be defined as biochemical changes 
in all tissues, involved in making respiratory organs; 
which finally affects the normal physiology of 
respiration.  
In the asymptomatic state (initial 1–2 days of 
infection), that is, the sanchaya stage (stage of 
accumulation), the inhaled virus SARS-CoV-2 enters 
into the body. In the prakopa stage, (stage of 
aggravation) it binds to epithelial cells in the nasal 
and buccal cavity producing symptoms like sneezing, 
rhinorrhoea, mild coughing. In this stage, replication 
starts and local propagation of the virus can be 
detected by nasal swabs. In the Prasara stage (stage 
of spread), the virus multiplication is further enhanced 
with spread causing the development of symptoms 
like fever, myalgia, malaise etc. In the next few days, 
the virus propagates and migrates down the 
respiratory tract along the communicating airways 
and localizes there (sthanasamshraya- stage of 
premonitory symptom). A complete or partial loss of 
the sense of smell (anosmia) has been reported in few 
cases of COVID-19 in this stage. Once the infection 
localizes in the Pranavahasrotas (respiratory tract), 
development of vyaktavastha (stage of manifestation) 
of the disease takes place with the manifestation of 
symptoms like Fever, Cough, Myalgia, Fatigue, 
Headache, Sputum production, Diarrhea, Malaise, 
Shortness of breath/dyspnoea and Respiratory distress 
etc. In this stage it will affect the other systems and 
large number of viral particles is released causing 
viremia affecting gastro intestinal & urinary system as 
well. If proper care and therapeutics are not 
administered in the vyaktavastha, it leads to the 
progression of next stage of the disease i.e., 
bhedavastha (stage of complication) and produces 
complications like severe pneumonia, septic shock, 
acute respiratory distress syndrome (ARDS), and 
multiorgan failure, resulting in death. The process of 
disease progress (samprapti/etiopathogenesis) is 
given in Figure 1. Its salient features are described 
below on the basis of the concept of “Shatkriyakal‖, 
(stages of disease manifestation and its 
management)
18
 which has been defined as 6 stages of 
disease pathogenesis. As of now, no objective 
parameter has been correlated with these stages of 
pathogenesis but in traditional knowledge has been 
properly defined. These are correlated to Nadi-
parikshan (Pulse analysis), which is also not well 
studied. Now, the efforts are being made on the basis 
of observational studies, as an instrument (Nadi-
Tarangani, based on the IPR of IIT, Bombay) has 
been developed, based on data of artificial 
intelligence. Thus, here, these terminologies of 
traditional knowledge can be considered as 
hypothesis, but it will act as the basis for formulating 
future research projects.  
1. Stage I-First three stages of Shatkriyakala, viz., 
Sanchaya, Prakopa & Prasara, mentioned above 
represents the incubation period of virus i.e. 
generally 2 -14 days, depending on the immune 
status of the host with predominance of Kapha & 
Vatadosha including Pitta. 
2. Stage II-It is the Sthanasamshraya stage of 
Shatkriyakala, in this stage there is an amalgamation 
of doshadushya in the pranavahasrotas leading to 
development of prodromal symptoms.  




3. Stage III-This is the Vyaktavastha stage of 
Shatkriyakala, and here stable clinical features 
associated with Tridosha are visualized. Depending 
on the immune status there will be an appearance 
of the complete symptoms or partial 
symptomatology. 
4. Stage IV-Bhedavastha stage of Shatkriyakala, at 
this stage, dhatupaka and specific complications 
are visualized along with above constitutional 
symptoms based on Tridoshaja dominance as in 
case of  
 Kapha predominant Sannipata: Acute 
Respiratory Distress Syndrome/Respiratory failure. 
 Vata predominant Sannipata: Cardiac arrest, 
Cardiomyopathy, Myocardial infarction.  
 Pitta predominant Sannipata: Alteration of 
Hepatic & Renal functions & finally leads to 
Hepato-renal syndrome and vascular coagulopathy. 
In fact it is situation ―progressing towards Multi-
organ failure‖ which has been defined as 
―Sannipath‖ in Ayurveda. 
 Sannipata: Multi-organ failure (MOF) and finally 
death. 
 
Sampraptighataka (Component of pathogenesis) 
 Nidana- Aupasargika/Sankramaka/Agantujanidan 
• Dosha-Predominance of Kapha-Vata associated 
with Pitta. 
• Dushya-Primary – Rasa, Rakta & secondary 
involvement of other dhatus, malas and Ojas.  
• Srotas –Pranavaha, Rasavaha, Raktavaha, 
Annavaha, Purishavaha. 
• SrotodustiLakshana- Atipravritti, Sangha and 
Vimargagamana 
• Udhbhavasthana-Nasa, Kantha, Uras. 
• Vyaktasthana –Nasa, Kantha, Uras, 
Sarvasharira. 
• Agni-Jatharagnimandya + dhatvagnivaishamya 
• Swabhava-Daruna and Ashukari 
• Prabhava-Sadhya, Kricchrasadhya or Asadhya 
depending upon Aturabala and Vyadhibala. 
Patient with comorbid factors associated with 




Regarding the treatment of COVID19 suspected 
people and corona positive patients a different 
protocol has been recommended. In addition to that, 
the prophylactic measures for general public and 
those who have been discharged from the hospital 
another set of diet, life style and food supplements 
have been recommended. The detailed treatment 
protocol is beyond the scope of this article 
(Segmentation of the target population as suggested in 
detailed guidelines has been described in Table 1) 
however, the prophylactic measures based on all the  
3 approaches of treatment i.e., Daiva Vyapashraya, 
Yukti Vyapashraya and Sattvavajaya have been 
described below.  
 
Fig. 1 — The Samprapti (Etiopathogenesis of disease progress as per shatkriyakal concept of Sushrut Samhita 
 




The Target Group 1, who is under quarantine and 
also for general population, who have no disease 
symptom but may have some kind of anxiety & stress 
due to this lockdown or pandemic situation, around 
the world, may follow the given protocol.  
 
Management of Anxiety and stress through Sattvavajaya and 
Daiva Vyapashraya Chikitsa 
 Counseling 
 Education about disease and its management. 
 To follow daily routine as per guidelines of 
Ayurveda. 
 Good sanitary and sleep practices with daily 
follow up sleep schedule of the same bedtime and 
wake up time. 
 Diet should be healthy and balanced contain a 
variety of different foods and drinks having wide 
range of nutrients and at right time 
 Exercise as per sharirabala and season  
Yama (Yama-ethical rules/ moral imperatives), 
Niyama (virtuous habits, behaviours and 
observances), Pranayama (control of breath 
observances), Dhyana (meditation) with Japa -
Mantra chanting (incantation) (according to one’s 




General measures/Atura Balavriddhi (Immunity Boosting) 
through Ojovardhaka and Rasayana (Immunity boosters)  
Daily intake of Go-dugdha (cow milk), Go-ghrita 
(cow ghee) or medicated Ghrita. Go Dugdha and  
Go-ghrita are included in Aajasrikarasayan, 
presumed to improve immunity. In fact milk intake 
has been considered as high protein diet in medical 
science
46
. In Ayurveda, milk of different animals have 
been described for different therapeutic potentials, but 
cow Milk as been defined as Balya and Jivaniya
47
. 
The Human milk provides a very wide range of 
nutrients and bioactive components, including 
immune factors, human milk oligosaccharides, and a 
commensal microbiota
48
. These factors are essential 
for interconnected processes including immunity 
programming and the development of a normal infant 
gastrointestinal microbiome, especially in infants
49
.  
A recent paper indirectly links high presence of 
Nicotinamide residue in Cow milk, which is related to 
be important factor in immono-boosting
50,51
 intake of 
medicated drinking water - Shadangapaniya
52
. It is 
the boiled water, supplemented with decoction  
of several herbs, which have shown to be  
immuno-booster and antioxidant in several studies.  
Thus, taking such medicinal plants on daily basis has 
been linked to good health and also for enhancement 
of appetite. Kwatha made with herbs like  





, Pippali (Piper 
longum Linn.)
55
 and Tulasi (Ocimum sanctum Linn.)
56
 
etc. that possess anti-viral activity or administration of 
boiled luke warm water may be used.  
 Daily intake of Kwatha (Water decoction)/Phanta 
of medicinal plants like Sunthi (Zingiber officinale 
Roxb.), Dalchini (Cinnamomum zeylanicum 
Table 1 — Target groups and their management principle 
SN  Target groups Treatment 
1. Target Group 1(A): Quarantine-Home/ general population  General Preventive measures 
2. Target Group 1(B): Quarantine Centre General Preventive measures  
3. Target Group 1(C): Health workers, Sanitation workers,  
Police cops, Media person  
Extensive preventive measures  
(along with psychological counseling where ever required) 
4. Target Group 2(A): Asymptomatic COVID19 +ve cases Ojovardhak Dravya 
(Immunity boosters) + 
Vishaghna (Anti-toxic) dravya specific to viral infection.+ 
Krimigna Drugs (Antimicrobials) 
5. Target Group 2(B): COVID19 +ve Subjects with  
Mild symptoms  
Curative and Symptomatic treatment  
 
6. Target Group 2(c): COVID19 +ve Subjects with  
Moderate symptoms 
Curative and Symptomatic treatment  
 
7. Target Group 2(D): COVID19 +ve patients with  
co-morbidity/Patients above 60 years of age. 
Condition specific + Curative and Symptomatic treatment  
8. Target Group 2(E): Pregnant women and Children Separate treatment protocol  
9. Target Group 3: Post treatment restorative  Treatment for recovery and Rejuvenation, prevent recurrence 
including Samshodhana chikitsa* 
*Samshodhana chikitsa should always be undergone under the supervision of qualified Panchkarma specialist after taking prior consent 
from the patient 




Breyn), Maricha (Piper nigrum Linn.), Yavani 
(Trachyspermum ammi Linn.), Guduchi (Tinospora 
cordifolia Willd Miers ex Hook f. & Thoms), 
Parijata (Nyctanthes arbortristis Linn.), Papita 
(Carica papaya Linn.), Tulasi (Ocimum sanctum 
Linn.), Trikatu. These herbs have proven report of 
antipyretic, anti-inflammatory and antioxidant 
potentials, already published in several 
experimental models
57-59
. Since these changes are 
reported in COVID-19 pathogenesis, so it could be 
suggested to combat the symptoms of this disease.  
 Use of single drug 
Guduchi (Tinospora cordifolia Willd Miers ex 
Hook f. & Thoms)
60
, Tulasi (Ocimum sanctum 
Linn.)
61





, Amalaki (Emblica 
officinalis Gaertn.)
64
, Ashwagandha (Withania 
somnifera Linn.)
65
, Yashtimadhu (Glycyrrhiza glabra 
Linn.)
66
, Draksha (Vitis vinifera Linn.)
67
, Kharjura 
(Phoenix sylvestris Roxb.) etc. possess 
immunomodulator activity and thus enhances 
immunity.  
 
 Use of formulation 
Rasayana formulations are the classical 
formulations, described in ayurvedic texts. They are 
claimed to have rejuvenation, health promotive and 
memory enhancer potentials as supported by classical 
references. They have medicinal plants as their 
components and all the plants have been studied 
separately for their therapeutic potentials like 
antiviral, anti inflammatory, antioxidant and 










 etc are some of such 
formulations. Their regular use as functional food has 
been reported to be health promotive by regulating 
several biochemical pathways, which is beyond the 
scope of this article. 
 
Other measures  
Dhoopana Karma (Fumigation) 
Dhoopana karma is a well-known procedure for 
disinfection. In the vishakta vayu chikitsa, Acharya 
Sushruta mentions the use of dhoopa to relieve the 
toxic effects of visha yukta vayu
72
. Most of the 
dhoopandravyas have essential oils which are volatile 
in nature. Their volatility becomes advantage in 
lowering microbial contamination in air and on 
difficult to reach surfaces. It creates an aseptic 
environment, kills microbes and thus, prevents 
opportunistic infection. Side by side if volatile 
substances are inhaled it interfere the multiplication of 
micro-organism in lung and thus reduces the 
microbial load
73,74
. In addition to this, dhoopana also 
help in inhaling the fumes of these medicinal plants, 
which is considered under ―Nasya” chikitsa. The 
olfactory receptors in nose get activated and regulate 
several metabolic pathways. Various phytochemicals 
like luteolin have shown antioxidant, anti-
inflammatory, antimicrobial, and neuroprotective 
activities through inhalation of their vapor or smoke. 
Various odorants have been developed. These 
molecules bind to the odorant receptors and induce 
signaling pathways in the olfactory sensory neurons, 
and transmit electrical signals to the brain, finally 
controlling the neuroendocrine system
75
. This process 
can be compared to the topical steroidal anti-
inflammatory drugs, such as glucocorticoids etc. 
which are routinely prescribed for treating upper 
airway inflammatory conditions, such as chronic 
rhinosinusitis
76
. It is already reported that nasal route 
of infection can cause encephalitis in humans and 
since olfactory route has been now accepted as an 
important pathway for viral entry into the CNS, then 
the same pathway could also be used for drug 
administration for effective treatment. This theory 
was hypothesized in 1935, that olfactory route is the 
portal for virus entry into the central nervous system 
(CNS). More recently, studies of antiviral innate and 
adaptive immune responses within the olfactory bulb 
suggest it provides early virologic control
77
. Drugs 
like Laksha (Laccifer lacca Kerr.), Haridra (Curcuma 
longa Linn.), Ativisha (Aconitum heterophylum 
Wall.), Haritaki (Terminalia chebula Retz.), Badi-ela 
(Amomum subulatum Roxb.), Ela (Elettaria 
cardimomum Maton.), Tagara (Velerina wallichii 
DC.), Kushtha (Saussureal appa C.B. Clarke), 
Priyangu (Callicarpa macrophylla Vahl.), Lobana 
(Styrax benzoin Dryand.), Rakshoghna dhupana, or 
with Guggulu (Commiphora mukul Hook ex Stocks), 
Raal (Shorea robusta Gaetrn.), Kapura 
(Cinnamomum camphora Nees. & Eberm), Jatamansi 
(Nardostachys jatamansi DC.), Yavani 
(Trachyspermum ammi Linn.) etc may be used for 
dhoopan, based on their easy availability and cost.  
 
Disinfectants 
In the vishakta bhoomi chikitsa, acharya sushruta 
explains the method of spraying/ sprinkling vishaghna 
and krimighna dravyas over the bhoomi or other 
surfaces which contain the toxic material
78
. 




Vishaghna dravyas having capacity to neutralize the 




Use of disinfectants prepared out of Vishagna 
dravyas like Haridra (Curcuma longa Linn.), Nimba 
(Azadirachta indica A. juss), Madayantika (Lawsonia 
inermis Linn.), Shirisha (Albizzia lebbeck Benth), 
Punarnava (Boerhavia diffusa Linn.) etc. 
 
Sanitizers 
Contact of visha yukta vastra, shayya, abhushana 
etc, Acharya sushruta explains the use of lepa of 
vishaghna dravyas as a remedy
81
. Sanitizers are the 
substance or fluid designed to kill germs on skin and 
objects. Hands are the most common mode of 
transmission of pathogens. Hence use of above drugs 




Use of hand sanitizers prepared out of Vishagna 
dravyas like Ghritakumari (Aloe vera Tourn. Ex 
Linn), Haridra (Curcuma longa Linn.), Nimba 
(Azadirachta indica A. juss), Madayantika (Lawsonia 
inermis Linn.), Koshataki (Luffa acutangula (Linn.) 
Roxb.), Shirisha (Albizzia lebbeck Benth), Punarnava 
(Boerhavia diffusa Linn.) etc. or available drugs.  
 
Kavala/Gandusha  
Gandusha is liquid or oil pulling/ holding of any 
liquid in mouth). Holding of medicated liquid of these 
herbal drugs in mouth can reduced the viral load and 
irritation in oropharyngeal region and imparts 
soothing effect in that area and strengthens gum and 
teath. Especially as virus remains in throat or oral 
cavity for long time and multiplies here. So this 
procedure, especially with Vishaghna and Krimighna 
dravyas will help. With kwatha of Haridra (Curcuma 
longa Linn.), Vidanga (Embelia ribes Burm. F.), 
Patha (Cissampelos pareira Linn.), Manjishta (Rubia 
cordifolia Linn.), Ela (Elettaria cardimomum 
Maton.), Brihati (Solanum indicum Linn.), 
Indravaruni (Cocculus hirsutus Linn. Diels), Tagara 
(Velerina wallichii DC.), Kushta (Saussureal appa 
C.B. Clarke), Triphala, Vasa (Adhatoda vasica 
Nees.), Kantkari (Solanum surratense Burm. F.) and 
Shirisha (Albizzia lebbeck Benth) etc. as per 
availability of drugs. Yavakshara and lavana mixed 
with oil or simple saline gargle.  
 
Nasya Karma (errhine therapy) (Pratimarsha Nasya)  
Due to lipoid in nature, nasya karma may interfere 
to the cell membrane of virus and it checks the 
multiplication of virus at nasal site and thus reduces 
viral load and severity of infection. May be given 
with Anutaila, Narikelataila, Sarshapataila, 
Goghrita, Shadabindutaila, etc. as per the 
requirement. 
 
Post disease treatment 
In case of those people who have been discharged 
from the hospital after treatment having Corona test 
negative but have fear of recurrence, should be 
primarily treated for their Psychological counseling 
and rejuvenation therapy by Medhya rasayana and 
Balya Rasayana to strengthen their physical 
components and maintain the normal physiology. 
Medhya rasayana drugs are advocated to the patients 
to nullify variety of mental stressors including disease 
Covid-19 itself and strengthen mental stamina while 
balya rasayana imparts physical strength and 
empower physiological fulfillment. The following 
treatment related to Ojovardhaka/Rasayana 










, Guduchighanvati or Sanshamanivati, 
Chyavanaprashavleha, Samshodhanachikitsa etc. 
along with nutritive diet, good sleep, physical 
exercise, procedures of Astang yoga may be included 
in the daily life practices. Utmost care should be taken 
while prescribing herbomineral preparations, like 
Rasasindura, Swarnabhasma Makard hwaja etc. to 
ensure their quality and safety aspect
87,88
. Only such 
products should be prescribed, manufactured abiding 
the standards, protocols and standard operative 
procedures (SOPs) mentioned in the official text book 
including pharmacopoeia. Drug dosing, anupana 
(vehicle) and other factors including individual 
humours (Dosha), individual constitution (Prakriti), 
time (Kaala), age (Vaya), digestive capacity (Agni) 
etc.
89
, should also be considered. The regular 
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